Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD
- 30 April 2009
- journal article
- research article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 103 (4), 516-524
- https://doi.org/10.1016/j.rmed.2008.12.014
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: A one year evaluation of safety and toleranceTherapeutic Advances in Respiratory Disease, 2008
- Effect of Nebulized Arformoterol on Airway Function in COPD: Results from Two Randomized TrialsCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2008
- Use of dry powder inhalers in COPDPublished by Hindawi Limited ,2007
- Dry Powder Inhalers: Which Factors Determine the Frequency of Handling Errors?Respiration, 2007
- Pharmacologic Interventions in Chronic Obstructive Pulmonary Disease: BronchodilatorsProceedings of the American Thoracic Society, 2007
- Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trialClinical Therapeutics, 2007
- The Effect of Tiotropium on Hyperinflation and Exercise Capacity in Chronic Obstructive Pulmonary DiseaseRespiration, 2006
- Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based OptimismProceedings of the American Thoracic Society, 2006
- Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEuropean Respiratory Journal, 2005
- A Benefit-Risk Assessment of Inhaled Long-Acting ??2-Agonists in the Management of Obstructive Pulmonary DiseaseDrug Safety, 2004